NXS 0.00% 22.0¢ next science limited

Next science wound gel technology, a novel agent that inhibits...

  1. 210 Posts.
    lightbulb Created with Sketch. 3


    Next
    science wound gel technology, a novel agent that inhibits biofilm development by gram-positive and gram-negative wound pathogens.


    The antimicrobial agent, Next-Science, inhibits the development of Staphylococcus aureus and Pseudomonas aeruginosa biofilms on tympanostomy tubes.


    Clinical Assessment of a Biofilm-disrupting Agent for the Management of Chronic Wounds Compared With Standard of Care: A Therapeutic Approach.


    Topical Treatment With an Agent Disruptive to P. acnes
    Biofilm Provides Positive Therapeutic Response: Results of a Randomized Clinical Trial.

    Again, it would be great to keep this to the science behind NS, as I'm sure there are plenty more discussion points. Congratulations to all holders; hopefully more to come!




 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.